Volume 180, Issue 4, Supplement , Pages 1810-1813, October 2008
Aberrant Expression of Ovary Determining Gene FOXL2 in the Testis and Juvenile Granulosa Cell Tumor in Children
Purpose
FOXL2 is the earliest known marker of ovarian differentiation in mammals. It is involved in ovarian somatic cell differentiation and further follicle maintenance. FOXL2 is not implicated in determination of the male gonad and it is absent in the testis. We investigated whether the rare JGCTT (juvenile granulose cell tumor of the testis), named for its histological similarity to ovarian tumor, could be the first illustration of aberrant expression of this ovary determining gene in the human testis.
Materials and Methods
Between 1990 and 2004, 3 boys with JGCTT were reported from the TGM95 database of the French Society for Childhood Cancer and from 8 pediatric endocrinology centers. Orchiectomy was performed in these patients. Immunohistochemistry of FOXL2, and co-immunofluorescence of FOXL2 and SOX9 were performed on tumor sections.
Results
Testicular tumor cells showed aberrant expression of FOXL2, which resembled normal ovarian granulosa cells. The localization of FOXL2 expression was nuclear without any cytoplasmic sequestration, suggesting that FOXL2 had biological activity. Conversely SOX9, which is present in the nucleus of normal testicular cells, was sequestered in the cytoplasm of granulosa tumor cells or markedly under expressed in the nuclei. In this case of residual SOX9 nuclear expression the expression of FOXL2 and SOX9 was mutually exclusive.
Conclusions
To our knowledge we report the first human model of aberrant intratesticular expression of an ovary determining gene along with the extinction of SOX9 and the transdifferentiation of a testicular cell into a granulosa tumor cell.
Key Words: testis, granulosa cell tumor, FOXL2 protein, human, sox-9 transcription factor, sex determination (genetics)
Abbreviations and Acronyms: FOXL2, forkhead box L2, HST, Hoechst dye, JGCTT, juvenile granulosa cell tumor of testis, SOX9, SRY Y-box 9, SRY, sex determination region, Y chromosome
To access this article, please choose from the options below
Study received approval from the French Society for Childhood Cancer review board.
Supported by National Grant ARC: JR/MLD/MDV-P05/5 from the Association de Recherche contre le Cancer.
PII: S0022-5347(08)00692-7
doi:10.1016/j.juro.2008.03.097
© 2008 American Urological Association. Published by Elsevier Inc. All rights reserved.
Volume 180, Issue 4, Supplement , Pages 1810-1813, October 2008

